Table 3 Baseline characteristics of the study participants according to ALT and AST quartiles
Characteristic | ALT (U/L) | P-values for trend | AST (U/L) | P-values for trend | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Q1 (≤ 9) | Q2 (10–12) | Q3 (13–18) | Q4 (≥ 19) | Q1 (≤ 17) | Q2 (18–20) | Q3 (21–23) | Q4 (≥ 24) | |||
Age (year) | 18.50 ± 1.05 | 18.49 ± 1.01 | 18.53 ± 0.98 | 18.56 ± 0.98 | 0.162 | 18.50 ± 1.04 | 18.54 ± 1.05 | 18.54 ± 0.98 | 18.48 ± 0.94 | 0.651 |
BMI (kg/m2) | 20.89 ± 2.38 | 21.56 ± 2.86 | 22.29 ± 3.03 | 25.15 ± 4.21 | 0.000 | 21.68 ± 2.81 | 21.69 ± 2.96 | 22.22 ± 3.32 | 24.11 ± 4.5 | 0.000 |
SBP (mmHg) | 110.01 ± 11.82 | 111.42 ± 12.6 | 115.97 ± 13.35 | 120.49 ± 14.89 | 0.000 | 112.39 ± 12.58 | 112.20 ± 13.08 | 114.41 ± 13.54 | 118.25 ± 15.13 | 0.000 |
DBP (mmHg) | 69.18 ± 9.85 | 69.96 ± 10.22 | 71.06 ± 10.38 | 74.21 ± 11.24 | 0.000 | 70.27 ± 10.11 | 69.99 ± 10.19 | 70.91 ± 10.36 | 73.07 ± 11.44 | 0.000 |
GLU (mmol/L) | 4.56 ± 0.40 | 4.57 ± 0.38 | 4.56 ± 0.39 | 4.58 ± 0.44 | 0.560 | 4.58 ± 0.41 | 4.57 ± 0.40 | 4.57 ± 0.38 | 4.54 ± 0.42 | 0.077 |
TC (mmol/L) | 3.97 ± 0.60 | 4.02 ± 0.65 | 4.00 ± 0.66 | 4.25 ± 0.79 | 0.000 | 3.96 ± 0.60 | 4.00 ± 0.65 | 4.08 ± 0.69 | 4.21 ± 0.78 | 0.000 |
TG (mmol/L) | 0.75 ± 0.26 | 0.78 ± 0.34 | 0.82 ± 0.39 | 1.01 ± 0.55 | 0.000 | 0.77 ± 0.28 | 0.80 ± 0.35 | 0.85 ± 0.43 | 0.95 ± 0.53 | 0.000 |
HDL-C (mmol/L) | 1.47 ± 0.25 | 1.47 ± 0.27 | 1.40 ± 0.28 | 1.30 ± 0.28 | 0.000 | 1.44 ± 0.26 | 1.43 ± 0.27 | 1.43 ± 0.27 | 1.36 ± 0.29 | 0.000 |
LDL-C (mmol/L) | 1.98 ± 0.45 | 2.00 ± 0.50 | 2.06 ± 0.53 | 2.36 ± 0.66 | 0.000 | 2.01 ± 0.47 | 2.03 ± 0.51 | 2.10 ± 0.56 | 2.27 ± 0.66 | 0.000 |